This article is intended for informational and educational use only and should not be interpreted as medical advice. Speak with your cardiologist before beginning any new cognitive enhancement program, particularly if you take cardiac medications or have a seizure history. UTCardiothoracicSurgery.com Editorial Team | July 2026. This article may contain affiliate links. Purchases made through links may earn a commission at no additional cost to you, without affecting editorial objectivity. FTC disclosure required by 16 C.F.R. Part 255.
Quick Answer: The Genius Song is a digital audio program using brainwave entrainment (binaural beats and isochronic tones) to promote focus and mental clarity. It is not a supplement or medical device. The underlying neuroscience is real but modest in effect. Cardiac patients should be aware that binaural beat stimulation has theoretical interactions with autonomic nervous system regulation — relevant for those on beta-blockers or anti-arrhythmic medications.
In This Article
The Cardiac Angle on Brainwave Audio Programs
Brainwave entrainment reviews rarely mention cardiovascular considerations, but they should. The autonomic nervous system — which regulates heart rate, blood pressure, and cardiac rhythm — is directly influenced by brainwave state. Techniques that shift brainwave activity from beta (alert) to theta (deeply relaxed) or vice versa can modulate sympathetic and parasympathetic tone. For healthy individuals, these shifts are benign. For patients on beta-blockers, calcium channel blockers, or anti-arrhythmic drugs — medications that already modulate autonomic cardiac control — the theoretical overlap deserves discussion with a prescribing physician. This review evaluates The Genius Song with these interactions in mind.
What The Genius Song Actually Is
The Genius Song is a digital audio product marketed as a cognitive enhancement tool. It uses binaural beats — presenting slightly different frequencies to each ear via headphones to produce a perceived “beat” at the difference frequency — along with isochronic tones (rhythmic pulses of sound). The marketing references a “7-minute brain trick” and implies rapid cognitive improvement, though the program may also include 12-minute session formats. The product is delivered as downloadable audio files.
The neurophysiological principle at the foundation — frequency following response, in which brainwave patterns tend to synchronize with external rhythmic stimuli — is documented in peer-reviewed literature and has been studied for decades. The distinction between this established principle and the product's marketing claims is important: while entrainment occurs, the magnitude of cognitive enhancement from any single commercial audio track is generally modest by research standards.
Marketing Claims Compared to the Evidence
The marketing for The Genius Song suggests transformative cognitive improvements — enhanced IQ, genius-level thinking, dramatic focus gains. The peer-reviewed literature on brainwave entrainment tells a more measured story. A 2023 meta-analysis in Frontiers in Human Neuroscience found statistically significant but small-to-moderate effects of binaural beats on attention and anxiety reduction. Effects on memory, creativity, and IQ remain inconsistent across studies and are not reliably demonstrated at the individual product level.
The marketing materials also show inconsistency across promotional platforms — some emphasize Gamma wave targeting (associated with higher-order cognition) while others reference Theta waves (associated with deep relaxation). These target different and partially opposing brain states, suggesting the marketing is more aspirational than technically precise. The Genius Song itself has not undergone published independent clinical evaluation.
Cardiac Safety Profile
The Genius Song is an audio file — it involves no ingestion, injection, or physical device contact. Direct pharmacological interaction with cardiac medications does not apply. However, the autonomic nervous system effects of brainwave entrainment are relevant for cardiac patients:
- Beta-blockers (metoprolol, atenolol, carvedilol): These medications reduce sympathetic nervous system activity. Brainwave entrainment targeting theta or delta states may compound parasympathetic dominance, theoretically increasing the risk of excessive bradycardia or lightheadedness in susceptible individuals. While this is a theoretical rather than documented clinical concern for audio products, patients on high-dose beta-blockers should be aware.
- Anti-arrhythmic medications (amiodarone, flecainide, sotalol): These drugs modulate cardiac electrical activity. There is no direct mechanism by which binaural beats would interact with anti-arrhythmic pharmacology, but patients with arrhythmia histories should note that deep relaxation techniques can occasionally unmask or modify perceived heart rhythm patterns.
- Seizure history: Binaural beats and isochronic tones involve rhythmic sensory stimulation. While audio-only entrainment is generally considered lower risk than photic (visual) stimulation, individuals with epilepsy or seizure disorders should consult their neurologist before using any brainwave entrainment product. This is relevant for cardiac patients because seizure activity can trigger cardiac arrhythmias.
- Anxiety and panic disorders (common comorbidity with cardiac conditions): Some users report that brainwave entrainment can temporarily increase anxiety, particularly during initial sessions. Patients with cardiac anxiety or panic disorder should begin with short sessions and monitor their response.
Overall cardiac risk: Very low for most patients. Theoretical considerations exist for those on high-dose beta-blockers or with seizure histories.
What Users Report
User feedback on The Genius Song describes a common pattern: many report increased calm, reduced mental noise, and modestly improved focus within the first week of daily use. Fewer users report the dramatic cognitive breakthroughs implied by the marketing. Individual response varies significantly based on personal neurophysiology, listening environment, and expectations. The research literature supports this pattern — brainwave entrainment generally produces subtle to moderate effects, not transformational ones.
Cost and Access
The Genius Song is sold as a digital download through various online promotional platforms. Pricing structures and included materials may differ depending on the specific offer page accessed. The product generally falls in the budget-friendly range for digital wellness programs. Refund policy details vary by vendor and should be confirmed before purchase.
Pricing is subject to change. Verify current pricing on the manufacturer's official listing.
Buyer Takeaway
The Genius Song is built on real neuroscience (frequency following response) packaged with marketing that significantly overpromises relative to the evidence. For cardiac patients, the product is very low risk as an audio-only tool, but those on beta-blockers or anti-arrhythmic medications should be aware of the theoretical autonomic overlap. This product is not a cognitive remarkable — it is a relaxation and focus tool that some users find helpful and others find unremarkable. The most honest assessment: try it if you are curious about brainwave entrainment, set expectations at “subtle and variable,” and discuss any concerns with your cardiologist if you are on autonomic-modulating cardiac medications.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.
Related reading: Brain Song Audio Program Review 2026: Cognitive Claims and Evidence Assessment | Delete Script Audio Program Review 2026: Brain Reprogramming Claims Examined